Anabolic Steroid Isomer (DEA internal) (Drug Enforcement Administration)

Anthony Roberts filed this request with the Drug Enforcement Administration of the United States of America.
Tracking #

19-00856-F

Multi Request Anabolic Steroid Isomer (DEA internal)
Est. Completion None
Status
No Responsive Documents

Communications

From: Anthony Roberts


To Whom It May Concern:

Pursuant to the Freedom of Information Act, I hereby request the following records:

DEA documents that mention anabolic steroid isomers (and/or“isomers of anabolic steroids”). This request seeks to ascertain whether (or not) DEA has privately mentioned, referenced, or otherwise discussed this 2005 notice:

https://www.deadiversion.usdoj.gov/fed_regs/rules/2005/fr1216.htm

Specifically, DEA has promulgated that the Anabolic Steroid Control Act of 2004 resulted in “Removal of the automatic scheduling of isomers of steroids listed as Schedule III anabolic steroids.”

This request is for any correspondence, plus internal and external documents not limited to email correspondences, white papers, and opinions that mentions anabolic steroid isomers and/or reaffirms or contradicts the quoted portion found in the link above.

This request should incorporate such documents as requested above that have been produced any time from December of 2014 through August 23, 2019.

The requested documents will be made available to the general public, and this request is not being made for commercial purposes.

In the event that there are fees, I would be grateful if you would inform me of the total charges in advance of fulfilling my request. I would prefer the request filled electronically, by e-mail attachment if available or CD-ROM if not.

Thank you in advance for your anticipated cooperation in this matter. I look forward to receiving your response to this request within 20 business days, as the statute requires.

Sincerely,

Anthony Roberts

From: Drug Enforcement Administration

Good Afternoon Mr. Roberts,
Please see the attached letter regarding your FOIA request dated August 24, 2019. If you have any questions or concerns, please feel free to call the mainline 202-307-7596.
Thank you,
Chelsea Scott | IBSS Paralegal II (CTR)
________________________________________
Freedom of Information/Privacy Act Unit (SARF)
Drug Enforcement Administration (DEA)

[http://intranet/sites/cp/cpi/PublishingImages/images/DEASeal-color.jpg]

PRIVACY ACT INFORMATION: This e-mail may contain information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). If the reader of this communication is not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If this communication has been received in error, please immediately delete all copies and notify me by e-mail.

From: Drug Enforcement Administration

Good Morning,

Per our records DEA sent a response on January 6, 2020. See the attached determination letter.

Best,

Ashley Williams, J.D.
IBSS Corp. Paralegal III Contractor, DEA FOI/PA Unit (FSRF)
Drug Enforcement Administration

[http://intranet/sites/cp/cpi/PublishingImages/images/DEASeal-color.jpg]

PRIVACY ACT INFORMATION: This e-mail may contain information that requires protection in compliance with the Privacy Act of 1974 (5 U.S.C. § 552a). If the reader of this communication is not the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If this communication has been received in error, please immediately delete all copies and notify me by e-mail.

Files

pages

Close